Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference
The presentation will be webcast live and can be accessed through the Investor Relations page at www.sophirisbio.com. A replay of the presentation will be available on the Company's website for 90 days.
Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Sophiris' current beliefs as well as assumptions made by and information currently available to Sophiris and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Sophiris in its public securities filings; actual events may differ materially from current expectations. Sophiris disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
View original content to download multimedia:http://www.prnewswire.com/news-releases/sophiris-bio-to-present-at-the-hc-wainwright-21st-annual-global-investment-conference-300909439.html
Company Contact: Peter Slover, Chief Financial Officer, (858) 777-1760; Corporate Communications and Media Contact: Jason Spark, Canale Communications, (619) 849-6005, firstname.lastname@example.org